Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,272 | 93 | 437 |
| Marketable Securities | 2,859 | N/A | N/A |
| TOTAL | $4,169 | $101 | $437 |
| Non-Current Assets | |||
| Intangibles | 222 | 382 | 542 |
| Other Non-Current Assets | 1,377 | 482 | 57 |
| TOTAL | $1,599 | $864 | $599 |
| Total Assets | $5,768 | $965 | $1,036 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 4 | 4 |
| Accounts payable and accrued liabilities | 992 | 2,401 | 1,629 |
| TOTAL | $992 | $2,405 | $1,633 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 638 | 582 |
| TOTAL | $N/A | $638 | $582 |
| Total Liabilities | $992 | $3,043 | $2,215 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 16,693 | N/A | N/A |
| Common Shares | 14 | 11 | 10 |
| Retained earnings | -8,815 | -6,212 | -4,400 |
| TOTAL | $4,776 | $-2,078 | $-1,179 |
| Total Liabilities And Equity | $5,768 | $965 | $1,036 |